SCHEMBL13130451

SCHEMBL13130451

CC(C)c1cccc(C(=O)NC2CCN(C)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.58
DRD4 P21917 1/20 0.56
ROCK1 Q13464 1/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CYP2C19 P33261 1/20 0.48
CARM1 Q86X55 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
TSHR P16473 1/20 0.47
SMYD3 Q9H7B4 1/20 0.47
ATR Q13535 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12026594 0.89 ROCK2 (0.59) ROCK2DRD4ROCK1NPC1RAB9A
SCHEMBL14441170 0.86 RAB9A (0.65) ROCK2ROCK1NPC1RAB9ACYP2C19
SCHEMBL21655002 0.85 DRD4 (0.52) ROCK2DRD4CARM1PRMT6MEN1
SCHEMBL24726480 0.85 RAB9A (0.68) ROCK2ROCK1NPC1RAB9ACYP2C19
SCHEMBL25647122 0.85 RAB9A (0.68) ROCK2ROCK1NPC1RAB9ACYP2C19
SCHEMBL27396502 0.85 RAB9A (0.68) ROCK2ROCK1NPC1RAB9ACYP2C19
SCHEMBL12089912 0.83 LMNA (0.53) ROCK2DRD4NPC1RAB9ACYP2C19
SCHEMBL21775965 0.83 ROCK2 (0.51) ROCK2DRD4ROCK1NPC1RAB9A
SCHEMBL13959947 0.82 NPC1 (0.72) NPC1RAB9ACYP2C19ALDH1A1MEN1
SCHEMBL31495180 0.81 KMT2A (0.66) ROCK2DRD4NPC1RAB9ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240657-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240657-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 ROCK2 1853/4885DRD4 638/4885ROCK1 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.